(NX) Quanex Building Products - Ratings and Ratios
Spacers, Vinyl, Seals, Hardware, Panels
Dividends
| Dividend Yield | 1.94% |
| Yield on Cost 5y | 1.57% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 94.3% |
| Payout Ratio | 24.2% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 60.0% |
| Value at Risk 5%th | 85.9% |
| Relative Tail Risk | -12.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.81 |
| Alpha | -59.66 |
| CAGR/Max DD | -0.16 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.635 |
| Beta | 1.328 |
| Beta Downside | 0.570 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.35% |
| Mean DD | 25.77% |
| Median DD | 23.42% |
Description: NX Quanex Building Products November 18, 2025
Quanex Building Products Corp. (NYSE: NX) manufactures a broad portfolio of fenestration components-including insulating glass spacers, vinyl profiles, screens, seals, and hardware-as well as non-fenestration products such as solar-panel sealants, trim moldings, and commercial access solutions. The company distributes these items globally through a mix of direct sales, representatives, distributors, and independent agents, serving original equipment manufacturers in the building-products sector. Founded in 1927 and headquartered in Houston, Texas, Quanex operates across the United States, Europe, Canada, and Asia.
Key quantitative drivers to watch: (1) Revenue growth has averaged ~5 % YoY over the past three years, buoyed by rising housing-starts and renovation activity; (2) Operating margins hover around 7-8 %, reflecting a cost-advantaged position in flexible glass spacers, but are sensitive to raw-material price volatility (e.g., vinyl resin and aluminum); and (3) The company’s exposure to energy-efficiency trends-particularly building-code mandates for low-U windows-offers upside potential, while a slowdown in residential construction could compress demand. Current leverage is modest (debt-to-EBITDA ≈ 2.2×), but any material increase in interest rates could affect financing costs.
For a deeper quantitative assessment, you may find ValueRay’s detailed valuation metrics and scenario analysis useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (-284.3m TTM) > 0 and > 6% of Revenue (6% = 110.4m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -8.86pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 17.32% (prev 16.05%; Δ 1.27pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 82.1m > Net Income -284.3m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 2.20 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (46.4m) change vs 12m ago 40.14% (target <= -2.0% for YES) |
| Gross Margin 24.18% (prev 21.79%; Δ 2.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 129.3% (prev 123.9%; Δ 5.41pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -3.87 (EBITDA TTM -127.0m / Interest Expense TTM 60.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.31
| (A) 0.16 = (Total Current Assets 583.3m - Total Current Liabilities 264.7m) / Total Assets 1.97b |
| (B) 0.08 = Retained Earnings (Balance) 148.8m / Total Assets 1.97b |
| (C) -0.16 = EBIT TTM -232.1m / Avg Total Assets 1.42b |
| (D) 0.09 = Book Value of Equity 118.8m / Total Liabilities 1.26b |
| Total Rating: 0.31 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 37.50
| 1. Piotroski 4.0pt |
| 2. FCF Yield 1.92% |
| 3. FCF Margin 1.49% |
| 4. Debt/Equity 1.22 |
| 5. Debt/Ebitda -6.37 |
| 6. ROIC - WACC (= -18.90)% |
| 7. RoE -30.72% |
| 8. Rev. Trend 59.77% |
| 9. EPS Trend -32.38% |
What is the price of NX shares?
Over the past week, the price has changed by +19.28%, over one month by +25.34%, over three months by +15.34% and over the past year by -41.91%.
Is NX a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28 | 69.5% |
| Analysts Target Price | 28 | 69.5% |
| ValueRay Target Price | 15.7 | -4.7% |
NX Fundamental Data Overview December 11, 2025
P/E Forward = 6.2539
P/S = 0.3398
P/B = 0.8678
P/EG = 0.8126
Beta = 0.973
Revenue TTM = 1.84b USD
EBIT TTM = -232.1m USD
EBITDA TTM = -127.0m USD
Long Term Debt = 695.6m USD (from longTermDebt, last quarter)
Short Term Debt = 41.6m USD (from shortTermDebt, last quarter)
Debt = 875.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 809.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.43b USD (625.3m + Debt 875.4m - CCE 66.3m)
Interest Coverage Ratio = -3.87 (Ebit TTM -232.1m / Interest Expense TTM 60.0m)
FCF Yield = 1.92% (FCF TTM 27.5m / Enterprise Value 1.43b)
FCF Margin = 1.49% (FCF TTM 27.5m / Revenue TTM 1.84b)
Net Margin = -15.45% (Net Income TTM -284.3m / Revenue TTM 1.84b)
Gross Margin = 24.18% ((Revenue TTM 1.84b - Cost of Revenue TTM 1.40b) / Revenue TTM)
Gross Margin QoQ = 21.02% (prev 29.04%)
Tobins Q-Ratio = 0.73 (Enterprise Value 1.43b / Total Assets 1.97b)
Interest Expense / Debt = 1.62% (Interest Expense 14.2m / Debt 875.4m)
Taxrate = 2.88% (-8.19m / -284.2m)
NOPAT = -225.4m (EBIT -232.1m * (1 - 2.88%)) [loss with tax shield]
Current Ratio = 2.20 (Total Current Assets 583.3m / Total Current Liabilities 264.7m)
Debt / Equity = 1.22 (Debt 875.4m / totalStockholderEquity, last quarter 717.4m)
Debt / EBITDA = -6.37 (negative EBITDA) (Net Debt 809.1m / EBITDA -127.0m)
Debt / FCF = 29.45 (Net Debt 809.1m / FCF TTM 27.5m)
Total Stockholder Equity = 925.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -14.41% (Net Income -284.3m / Total Assets 1.97b)
RoE = -30.72% (Net Income TTM -284.3m / Total Stockholder Equity 925.5m)
RoCE = -14.32% (EBIT -232.1m / Capital Employed (Equity 925.5m + L.T.Debt 695.6m))
RoIC = -13.44% (negative operating profit) (NOPAT -225.4m / Invested Capital 1.68b)
WACC = 5.47% (E(625.3m)/V(1.50b) * Re(10.91%) + D(875.4m)/V(1.50b) * Rd(1.62%) * (1-Tc(0.03)))
Discount Rate = 10.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 18.59%
[DCF Debug] Terminal Value 70.13% ; FCFE base≈52.3m ; Y1≈57.1m ; Y5≈72.1m
Fair Price DCF = 17.39 (DCF Value 797.9m / Shares Outstanding 45.9m; 5y FCF grow 10.43% → 3.0% )
EPS Correlation: -32.38 | EPS CAGR: -38.40% | SUE: -4.0 | # QB: 0
Revenue Correlation: 59.77 | Revenue CAGR: 15.15% | SUE: 0.59 | # QB: 0
EPS next Quarter (2026-01-31): EPS=0.12 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=4
EPS next Year (2026-10-31): EPS=2.21 | Chg30d=+0.000 | Revisions Net=-3 | Growth EPS=+10.4% | Growth Revenue=+0.6%
Additional Sources for NX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle